Adaptive Biotechnologies ADPT Return on equity

Return on equity at other companies

Biodesix, Inc.BDSX

-540%-1,719pp

Guardant HealthGH

-438.1%-1,655pp

Natera, Inc.NTRA

-29%+4.1pp

GeneDx HoldingsWGS

-30.4%—

Personalis, Inc.PSNL

-41.4%-6.7pp

Myriad GeneticsMYGN

-76.7%-98.4pp

FAQ

What is Adaptive Biotechnologies's return on equity?

Adaptive Biotechnologies (ADPT) reported return on equity of -24.4% in Q1 2026.

How has Adaptive Biotechnologies's return on equity changed year-over-year?

Adaptive Biotechnologies's return on equity increased by 59.9% year-over-year, from -61% to -24.4%.

What is the long-term trend for Adaptive Biotechnologies's return on equity?

Over 5 years (2020 to 2025), Adaptive Biotechnologies's return on equity has grown at a 4.9% compound annual growth rate (CAGR), from -22.3% to -28.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.